Partnership for first-in-class cancer and CRM treatments
Boehringer Ingelheim partners with OSE Immunotherapeutics to develop first-in-class cancer and CRM treatments
Search
Survodutide (BI 456906)
Survodutide (BI 456906)
Survodutide (BI 456906)
BI 456909
Stargardt Disease
Stargardt Disease is a hereditary condition which causes degeneration of cells in the retina at the back of the eye.
Diabetes
Diabetes
Phase 3 studies survodutide obesity and overweight
Phase 3 studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
Interstitial lung disease in rheumatoid arthritis (RA-ILD)
Interstitial lung disease (ILD) is the most common type of lung condition associated with the systemic autoimmune disease rheumatoid arthritis (RA).
Eyes on Retina. The Podcast
Hear from experts and people living with retinal diseases such as wet age-related macular degeneration (AMD), stargardt disease and diabetic retinopathy.
cardiometabolic_retinal_partner_interests.pdf
CardioMetabolic_infographic_Update_2021.pdf
CardioMetabolic_Flyer_BIO_2022.pdf
Partnering_In_CARDIOMETABOLIC_0.pdf
Partnering in Cardiometabolic JAN 2023
Partnering in Cardiometabolic JAN 2023 Corporate
CardioMetabolic_infographic_FINAL Dec 18 V2.pdf
cardiometabolic_flyer_bio_2019.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
Partnering with Lifebit to detect global disease outbreaks
Boehringer Ingelheim partners with Lifebit to detect global infectious disease outbreaks
EMPA-KIDNEY trial early stop due to positive efficacy
EMPA-KIDNEY, the largest SGLT2 inhibitor trial in chronic kidney disease, will stop early due to clear evidence of positive efficacy
Immunology Respiratory Research
Find out more about our research and development in Immunology & Respiratory diseases
Connect the Docs
Experts discuss interconnectivitiy of heart failure, diabetes, and kidney disease and the importance of early diagnosis.
FDA approves Jardiance treatment chronic kidney disease
U.S. FDA approves Jardiance® for treatment of adults with chronic kidney disease
Facts About IPF
IPF is a debilitating and fatal lung disease.
Chronic kidney disease in cats
Detect and manage chronic kidney disease and high blood pressure in cats
World Heart Day 2021
Cardiovascular diseases, including heart disease, are the leading cause of death and disability worldwide and are closely linked to kidney and metabolic diseases.